Anna Nordmark

Physiologically based pharmacokinetic modeling in regulatory decision‐making at the European Medicines Agency

Elisa Luzon, Kevin Blake, Susan Cole et al. · Clinical Pharmacology & Therapeutics · 2016 · 129 citations

European Medicines Agency, Physiologically Based Pharmacokinetics, Pharmacokinetic Modeling +14

EXPRESSION OF CYP3A ISOFORMS AND P‐GLYCOPROTEIN IN HUMAN STOMACH, JEJUNUM AND ILEUM

Roberto Canaparo, Niklas Finnström, Loredana Serpe et al. · Clinical and Experimental Pharmacology and Physiology · 2007 · 94 citations

Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report

Sandra Suarez‐Sharp, Michael R. Cohen, Filippos Kesisoglou et al. · The AAPS Journal · 2018 · 77 citations

Drug Test, Analytical Chemistry, Workshop Summary Report +2

Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity

Sebastian Härtter, Anna Nordmark, Dirk‐Matthias Rose et al. · British Journal of Clinical Pharmacology · 2003 · 76 citations · Full text

Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation

Terry Shepard, Graham Scott, Susan Cole et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 71 citations · Full text

Engineering, Physiological Status, Physiological Regulation +21